Yuyu Pharma Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Yuyu Pharma cash flow conversion efficiency. Based on the latest financial reports, Yuyu Pharma (000220) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Yuyu Pharma (2011–2024)

Cash flow conversion efficiency of Yuyu Pharma from 2011 to 2024. This chart illustrates how Yuyu Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Yuyu Pharma share price for real-time trading data and today's change.

Yuyu Pharma Cash Flow Conversion Ratio Explained

Yuyu Pharma cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Yuyu Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma ranked by their cash flow conversion efficiency. Also see Yuyu Pharma (000220) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Nandan Denim Limited NSE:NDL	0.071x
NK Co. Ltd KO:085310	0.015x
PCF Group SA WAR:PCF	0.081x
Fodelia HE:FODELIA	0.042x
Song Ho Industrial Co Ltd TWO:5016	0.013x
Swiss Steel Holding AG SW:STLN	-0.244x
SuNam Co. Ltd KQ:294630	-0.133x
IHQ Inc KO:003560	0.072x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma from 2011 to 2024. Review 000220 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	+277.82%
2013-12-31	₩72.28 Billion ≈ $48.98 Million	₩-775.17 Million ≈ $-525.32K	-0.011x	-111.45%
2012-12-31	₩69.50 Billion ≈ $47.10 Million	₩6.51 Billion ≈ $4.41 Million	0.094x	-5.64%
2011-12-31	₩67.23 Billion ≈ $45.56 Million	₩6.67 Billion ≈ $4.52 Million	0.099x	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$40.03 Million

₩59.07 Billion KRW

Market Cap Rank

#22519 Global

#1455 in Korea

Share Price

₩3650.00

Change (1 day)

-1.08%

52-Week Range

₩3435.00 - ₩4740.00

All Time High

₩16106.03